Committee for Orphan Medicinal Products (COMP): 13-15 April 2021
Date:
13/04/2021 to 15/04/2021
Location:
European Medicines Agency, Amsterdam, the Netherlands
The Committee for Orphan Medicinal Products (COMP) is the committee that is responsible for reviewing applications for 'orphan medicinal product designation' for medicines intended for the diagnosis, prevention or treatment of rare diseases.
-
List item
COMP meeting report on the review of applications for orphan designation: April 2021 (PDF/181.25 KB)
First published: 22/04/2021
EMA/COMP/223759/2021 -
List item
Agenda - COMP agenda of the 13-15 April 2021 meeting (PDF/263.41 KB)
Draft
First published: 13/04/2021
EMA/COMP/173664/2021 -
List item
Minutes of the COMP meeting 13-15 April 2021 (PDF/416.72 KB)
Adopted
First published: 11/06/2021
EMA/COMP/222143/2021